CA3201123A1 - Methodes de traitement de troubles psychiatriques par brexpiprazole chez des patients obeses - Google Patents

Methodes de traitement de troubles psychiatriques par brexpiprazole chez des patients obeses

Info

Publication number
CA3201123A1
CA3201123A1 CA3201123A CA3201123A CA3201123A1 CA 3201123 A1 CA3201123 A1 CA 3201123A1 CA 3201123 A CA3201123 A CA 3201123A CA 3201123 A CA3201123 A CA 3201123A CA 3201123 A1 CA3201123 A1 CA 3201123A1
Authority
CA
Canada
Prior art keywords
brexpiprazole
dose
days
day
cyp2d6
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CA3201123A
Other languages
English (en)
Inventor
Sundar Srinivasan
Christina Chow
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Lake O'hara LLC
Original Assignee
Lake O'hara LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US17/139,690 external-priority patent/US20220202810A1/en
Priority claimed from US17/139,627 external-priority patent/US11229644B1/en
Application filed by Lake O'hara LLC filed Critical Lake O'hara LLC
Publication of CA3201123A1 publication Critical patent/CA3201123A1/fr
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

La présente divulgation concerne des méthodes de démarrage d'un traitement par brexpiprazole chez des patients atteints de schizophrénie ou d'une dépression majeure. La présente divulgation concerne en outre des posologies modifiées pour les patients obèses et/ou pour les patients qui sont de mauvais métaboliseurs du CYP2D6. Dans des modes de réalisation, les posologies modifiées administrent une dose quotidienne doublée lors du démarrage du traitement.
CA3201123A 2020-12-31 2021-02-03 Methodes de traitement de troubles psychiatriques par brexpiprazole chez des patients obeses Pending CA3201123A1 (fr)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US17/139,690 2020-12-31
US17/139,690 US20220202810A1 (en) 2020-12-31 2020-12-31 Methods of treating psychiatric disorders in obese patients with brexpiprazole
US17/139,627 US11229644B1 (en) 2020-12-31 2020-12-31 Methods of treating psychiatric disorders in obese patients with brexpiprazole
US17/139,627 2020-12-31
PCT/US2021/016329 WO2022146462A1 (fr) 2020-12-31 2021-02-03 Méthodes de traitement de troubles psychiatriques par brexpiprazole chez des patients obèses

Publications (1)

Publication Number Publication Date
CA3201123A1 true CA3201123A1 (fr) 2022-07-07

Family

ID=82259620

Family Applications (1)

Application Number Title Priority Date Filing Date
CA3201123A Pending CA3201123A1 (fr) 2020-12-31 2021-02-03 Methodes de traitement de troubles psychiatriques par brexpiprazole chez des patients obeses

Country Status (5)

Country Link
EP (1) EP4271381A1 (fr)
JP (1) JP2024502431A (fr)
AU (1) AU2021412785A1 (fr)
CA (1) CA3201123A1 (fr)
WO (1) WO2022146462A1 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11229644B1 (en) 2020-12-31 2022-01-25 Lake O'hara Llc Methods of treating psychiatric disorders in obese patients with brexpiprazole
WO2023141634A2 (fr) * 2022-01-24 2023-07-27 Lake O'hara Llc Méthodes de traitement à base de brexpiprazole chez des patients obèses atteints de troubles psychiatriques

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2902781C (fr) * 2013-02-27 2020-12-29 Mochida Pharmaceutical Co., Ltd. Nouveau derive de pyrazole
PL3426250T3 (pl) * 2017-05-16 2022-08-08 Bow River LLC Leczenie pacjenta lekiem będącym substratem CYP3A4 przeciwwskazanym do jednoczesnego podawania z silnym inhibitorem CYP3A4
WO2020132522A1 (fr) * 2018-12-21 2020-06-25 The Regents Of The University Of California Traitement de troubles neurodéveloppementaux

Also Published As

Publication number Publication date
WO2022146462A1 (fr) 2022-07-07
EP4271381A1 (fr) 2023-11-08
AU2021412785A1 (en) 2023-06-22
JP2024502431A (ja) 2024-01-19

Similar Documents

Publication Publication Date Title
Horrigan et al. A phase 2 study of AMO-02 (Tideglusib) in congenital and childhood-onset myotonic dystrophy type 1 (DM1)
TWI776407B (zh) 激動劑形成之調配物及使用其之方法
JP6193592B2 (ja) ピルフェニドン療法を施す方法
JP2021510681A (ja) Ｃｙｐ３ａ４基質薬物による処置方法
JP2023075247A (ja) ウィルソン病を治療するためのビスコリンテトラチオモリブデート
CA3201123A1 (fr) Methodes de traitement de troubles psychiatriques par brexpiprazole chez des patients obeses
JP2021119189A (ja) ジストニアを治療するためのプリドピジンの使用
US11951105B2 (en) Methods of treating psychiatric disorders in obese patients with brexpiprazole
US20230414606A1 (en) Methods of treating psychiatric disorders in obese patients with brexpiprazole
US20220202810A1 (en) Methods of treating psychiatric disorders in obese patients with brexpiprazole
JP2023171774A (ja) ゴーシェ病を処置する方法
AU2020293739B2 (en) Composition comprising pridopidine and analog thereof for treating huntington disease and symptoms thereof
CA3048206C (fr) Mise en transition de patients de la vortioxetine a un inhibiteur de monoamine oxydase
US20230346718A1 (en) Method of treating, ameliorating and/or preventing depression
RU2781242C2 (ru) Способы лечения болезни гоше
Pigeolet et al. PII‐55: Retrospective population pharmacokinetic analysis of levetiracetam in Westerner and Japanese adults